ADRs End Higher; Yunji Inc. Climbs 144%
Dow Jones2026/08/19 20:31This article was automatically generated by Dow Jones using technology from Automated Insights.
International stocks trading in New York closed higher on Wednesday, as the S&P/BNY Mellon index of American depositary receipts gained 0.1% to 273.85.
The European index increased 0.3% to 246.00. The Asian index declined 0.4% to 360.60. The Latin American index added 1.1% to 264.70, while the emerging-markets index added 0.3% to 596.58.
Hong Kong's Yunji Inc. was the biggest leader during the session, soaring 144% to $4.25, and Macau-based CL Workshop Group Ltd. rocketed 31% to 49 cents. Lion Group Holding Ltd., which is based in Hong Kong, rounded out the top three leaders on Wednesday, with shares soaring 26% to 70 cents.
Amber International Holding Ltd., based in Hong Kong, posted the largest decline, plummeting 24% to 94 cents, followed by shares of Hong Kong's uCloudlink Group Inc., which plunged 16% to 41 cents. Shares of Ireland-based Trinity Biotech PLC tumbled 11% to $11.01.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 19, 2026 16:31 ET (20:31 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Rising energy prices increase inflation risks, Reserve Bank of Australia expected to implement the fourth rate hike of the year next week
As rising energy prices further highlight upward inflation risks, economists state that the Reserve Bank of Australia will raise its key interest rate next week and warn that there could be another hike in November.
Ark Invest increased its holdings of Meta Platforms shares by approximately 38.15 million dollars yesterday.
British Pound consolidates vs USD; bearish bias remains amid divergent Fed-BoE outlook

AI pharmaceutical company Iambic (IAM.US), supported by Nvidia, applies for US IPO to advance three early-stage cancer drugs
Iambic Therapeutics Inc. has filed for an initial public offering (IPO) in the United States.